Purpose: Few data exist on high cardiovascular risk (HCVR) prevalence within a primary prevention population. The goals of the present study were: 1) to assess HCVR distribution according to SCORE, in France, for high-risk primary care patients not treated for dyslipidemia; 2) to compare risk assessment by physician and risk SCORE estimate; 3) to define the excess of risk (ER) due to other risk factor than age.
Results: GPs (n=1147) included 9049 patients with the following characteristics: mean age: 68y; male: 57%; LDLc>1.3 g/L: 57%; smoking: 21%; HBP: 44%; type 2 diabetes: 21% HDL-c<0.4 g/L: 16%. According to SCORE, 50% of the patients were at HCVR. CVR was correctly assessed for 45.9% of the patients and under estimated for 62.8% HCVR patients. There was little correlation between GPs risk assessment and SCORE results: Kappa=0.078 [IC95%=0.062-0.094]; weighted Kappa=0.097 [0.082-0.112]. Mean ER increased with age, from 1.1/0.9% to 4.5/3.6% for male (50y to >75y))/female (60y to >75y). At the end of the study, 85% of the GP declared that SCORE was useful in HCVR identification and 87% declared that they will use it in the future.
Conclusion:
In France, 50% of the patients consulting in primary care with at least 1 RF on top of age and no lipid-lowering treatment have a high SCORE. GPs tend to underestimate their patient's risk as compared to objective SCORE risk assessment. Excess risk increases with age.
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Prevalence of hypertension among schoolchildren in Brazzaville (Congo)
Bertrand Ellenga Mbolla (1), Thierry Raoul Alexis Gombet (1), Annie Rachel Okoko (2), Gaston Ekouya Bowassa (2), Suzy Gisèle Kimbally-Kaky (2), Georges Marius Moyen (2) (1) CHU de Brazzaville, urgences, Brazzaville, Faculté des sciences de la santé, Université Marien gouabi, Département de médecine, Brazzaville, Congo Aim: To determine the prevalence of hypertension among schoolchildren in Brazzaville.
Patients and methods: a prevalence survey was conducted from March to May 2011 in five urban schools in Brazzaville. The survey was random at three levels. The variables studied were clinical and epidemiological.
Results: 603 children divided into 325 girls (54%) and 278 boys (46%) were examined. The average age was 11.8±3.6 years (range 5-18 years). There was 315 children (52.2%) from primary schools and 319 (53%) from private schools. The social level was average or higher in 360 cases (60%). The mean SBP was 112.8±13 mm Hg (range 79-150) and the mean DBP was 73.6±8.8 mm Hg (range 48-104). Obesity was noted in 25 cases (4.1%), and overweight in 47 cases (7.8%). Hypertension was found in 61 cases (10.1%) during the first screening, and in 20 cases (3.3%) during the second screening. Factors correlated with hypertension were obesity (OR 6.6, 95% CI 2-21) and overweight (OR 5.6, 95% CI 2-15).
Conclusion: the fight against obesity and overweight in our children by promoting food and physical activity which will reduce the incidence of hypertension.
Keywords: hypertension, children, school, Brazzaville
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Ramadan fasting and high sensitive CRP in patients with stable coronary artery disease: a pilot study Faouzi Addad (1), Majdi Amami (1), Nadia Hammami (1), Sami Gargouri (1), Sonia Marrakchi (2), Houssine Chammem (1), Wacef Ayedi (1), Afef Ben Halima (2), Ikram Kammoun (2), Sadek Yahlaoui (3), Salem Kachboura (2) (1) EPS Abderrahmen Mami, service de cardiologie, Ariana, Tunisie -(2) CHU A. Mami, service de cardiologie, Ariana, Tunisie -(3) EPS Abderrahmen Mami, department of medical biology, Ariana, Tunisie Introduction: Ramadan fasting is one of the five pillars observed by Muslim adults worldwide. Data on incidence of acute coronary syndrome during fasting Ramadan are scarce and conflicting. Inflammation plays a major role in atherothrombosis, and measurement of cardiac biomarkers such as High sensitive C-reactive protein (hs-CRP) may provide a strong independent predictor of future cardiac events.
Aim of this study: was to evaluate the effect of fasting during Ramadan on hs-CRP in patients with stable coronary artery disease (CAD).
Patients and Methods:
it was a prospective pilot study among 27 patients with stable CAD (within the last 6 months) who were observed before and at the end of Ramadan fasting. Patients were recruited from outpatients department. Twenty one were males and 6 were females with a mean age of 59±8.2 years (52-75 y). Fifteen patients had hypertension, 10 were smokers and 7 were diabetics. Blood was analyzed at the first visit was a week before the onset of Ramadan and the second visit at the third week of Ramadan. The assay of hs-CRP was done with the collected sera by Demeditec Diagnostics Systems Laboratories (Germany).
Results: Six patients were excluded for the second visit due to various reasons (break voluntary of fasting in two cases, 4 patients with concurrent inflammatory disorders e.g. rheumatoïd disease in 2 cases and intercurrent infections in two others). A total of 21 subjects were screened during this period. There was a significant reduction in hs-CRP during Ramadan compared before this period: 6.6±8.7 vs 3.8±5.5 (p <0.0001). The mean variation of hs-CRP during this holy period was -39.3±-20.9 (0% à -68.3%). The hs-CRP level was less than 3 mg/l in 10 patients (47.6%) before compared to 13 pts (62%) during Ramadan. The reduction of hs-CRP was independent of the risk factors or the dosage of statins.
Conclusion: The practice of fasting during the month of Ramadan by the people with stable CAD might be cardio-protective as it resulted in the lowering of hs-CRP.
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Cardiovascular risk prevalence in high risk primary care patients not treated with lipid-lowering treatment in France, results of an online study Eric Bruckert (1), Serge Kownator (2), Jean Dallongeville (3), Gennevieve Bonnelye (4), Florence Thomas-Delecourt (5), Pierre-Henri Delaage (6), Jean Ferrières (7) (1) APHP, Paris, France -(2) Thionville, France -(3) Institut Pasteur, Lille, France -(4) Kantar Health, Paris, France -(5) AstraZeneca, Rueil Malmaison, France -(6) AstraZeneca, Rueil Malmaison, France -(7) CHU Toulouse, Toulouse, France
Purpose: Few data exists on high cardiovascular risk (HCVR) prevalence within a primary prevention population. The goal of the study was to assess HCVR distribution, according to SCORE, in France for high-risk primary care patients not treated with lipid-lowering drug.
January 19 th , Saturday 2013
Results: Over a mean follow-up period of 30 months, the rate of recurrence was 8.9% per patient and per year. PE was unprovoked in 63 patients (52.5%). Mean duration of oral anticoagulation was 6 months. Compared to O blood type, the unadjusted hazard ratio (HR) of VTE recurrence for non-O blood type was 1.97 (95%CI, 0.91-4.26, p=0.07). B blood type exposed to a higher risk of VTE recurrence than O blood type with a HR of 2.6 (95%CI, 1.12-6.06, p=0.03). A and AB blood types were not associated with an increased risk of VTE recurrence when compared to O blood type.
Conclusion:
Non O blood type are involved not only in the occurrence of a first episode of VTE but tend to contribute to VTE recurrence. Patients with B blood type develop more VTE recurrence than others. The ABO blood type could be one of the characteristics to be studied for the determination of the length of anticoagulant treatment after a first episode of VTE
259
Relationships between chronic use of statins, presentation of acute coronary syndrome and one-year mortality after a first event in patients from the French MO ICA registries
Paul-Louis Vervueren (1), Vanina Bongard (1), Jean Dallongeville (2), Dominique Arveiler (3), Jean-Bernard Ruidavets (4), Philippe Amouyel (2), Aline Wagner (5), Annie Bingham (6), Meyer Elbaz (7), Jean Ferrières (8 Medicine, Epidemiology and Public Health, Strasbourg, France -(4) Inserm U1027, Département d'épidémiologie, Toulouse Cedex, France -(5) Faculté de Médecine, Laboratoire d'épidémiologie et de santé publique, Strasbourg Cedex, France -(6) Inserm U909, Paul Brousse Hospital, Villejuif, France -(7) Toulouse University Hospital, Department of Cardiology B, Toulouse Cedex 9, France -(8) CHU Rangueil, service de cardiologie B, Toulouse Cedex 9, France Purpose: Statins have demonstrated their efficacy in many situations to prevent cardiovascular risk. In this work we investigated the link between chronic use of statins, type of subsequent acute coronary syndrome (ACS), namely ST-elevation myocardial infarction (STEMI) or unstable angina/non ST-elevation myocardial infarction (UA/NSTEMI), early complications and their impact on one-year mortality in real life conditions.
Methods:
Our study was based on 2006 data from the French MONICA population-based registry which collects all cases of ACS occurring in people aged 35-74 in 3 French areas. The sample consisted of 1951 hospitalized incident ACS (72 were excluded because of missing data). Relationship between chronic use of statins and type of ACS or early complications (resuscitated cardiac arrests and shocks) were analyzed through logistic regression. Impact on one-year mortality was evaluated through Cox models. Analyses were adjusted for patients' characteristics (living area, age, gender and previous cardiovascular treatments).
Results: Before index event, the rate of statins treated patients was 18%. The percentage of UA/NSTEMI among all hospitalized ACS was 45%; 54.5% in patients with previous statins treatment and 42.9% in those without (p<0.0001). The adjusted odds ratio (OR) for UA/NSTEMI was 1.29 (p=0.049) for subjects with versus those without statins. There was a significant association between statins and early complications (adjusted OR 0.58; p=0.030). Statins treatment prior to event was associated with a significant decrease in one-year mortality with an adjusted HR equal to 0.62 (p=0.017).
Conclusions:
In our registry, people already treated with statins before an incident ACS had a lower rate of one-year mortality. This may result from a lower probability to develop STEMI, or early complications. However it remains difficult to assess from these observational data what is related to the treatment and what is related to potential confounding bias.
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Cognitive performance, cerebral oxygenation, exercise capacity and cardiac output in patients with coronary heart disease Vincent Gremeaux (1), Joffrey Drigny (2), Mathieu Gayda (2), Louis Bherer (3), Philippe Sosner (4), Martin Juneau (2), Anil Nigam (2 Objectives: Recent data suggested that coronary heart disease (CHD) is associated with non-amnesic mild cognitive impairment. Our purpose was to assess cognitive performances at rest, VO2max, cardiac output (CO), and cerebral hemodynamic changes during maximal exercise in patients with stable CHD.
Methods: 22 stable fit CHD patients (70,9±9,3 years), 10 healthy agematched (68,6±8,6 years), 10 middle aged controls and 10 young controls (< 40y) were included. We assessed cognitive performance with a standard battery of paper and pencil tests, maximal exercise test on ergocycle with gas exchange analysis with non-invasive CO measurement and Near-Infrared Spectroscopy (NIRS) oxygenation indices at the brain level.
Results:
There was no intergroup difference in VO2max or maximal CO between cardiac and healthy age-matched individuals. Some cognitive tests, especially for executive functioning, were significantly better for the healthy matched group (Trail Making Test-B; Inhibition/Flexibility Stroop Task and Backward Digit Span, p<0.05). For NIRS signals, we observed an increase in deoxyhemoglobin (HHb) for maximal intensities and the classical inverted Ushape curve for oxyhemoglobin (O2Hb) and hemoglobin difference (Hbdiff=O2Hb-HHb) in each group. Considering fitness, intra-CHD group
